About Ceban Pharmaceuticals
Ceban Pharmaceuticals is a company based in Breda (Netherlands) founded in 1980 was acquired by Medios AG in May 2024. Ceban Pharmaceuticals offers products and services including Medsen Apotheken, Ceban Compounding, and Ceban HomeCare. Ceban Pharmaceuticals operates in a competitive market with competitors including AmerisourceBergen, IDA Foundation, Lagaay, Mach 2 Pharmafreight and HI-Systems, among others.
- Headquarter Breda, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ceban B.V.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ceban Pharmaceuticals
Ceban Pharmaceuticals offers a comprehensive portfolio of products and services, including Medsen Apotheken, Ceban Compounding, and Ceban HomeCare.
Provides personalized pharmaceutical care through retail outlets
Specializes in custom pharmaceutical compounding services
Delivers pharmaceutical support for home-based patient care
Funding Insights of Ceban Pharmaceuticals
Detailed funding history for Ceban Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ceban Pharmaceuticals
Ceban Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Medios AG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delivers specialty pharmaceuticals and advanced therapies for healthcare stakeholders.
|
Locked | Locked | Locked |
Investor details for Ceban Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ceban Pharmaceuticals
Investment portfolio details for Ceban Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ceban Pharmaceuticals
Detailed financials for Ceban Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ceban Pharmaceuticals Comparisons
Peer comparison for Ceban Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ceban Pharmaceuticals
Ceban Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, IDA Foundation, Lagaay, Mach 2 Pharmafreight and HI-Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Supplies essential medicines and medical goods to countries in need.
|
|
| Locked | Locked | Locked |
Healthcare products including equipment and supplies are distributed by Lagaay.
|
|
| Locked | Locked | Locked |
Provider of freight and distribution services for pharmaceutical products, setting industry standards
|
|
| Locked | Locked | Locked |
Pharmaceutical products are supplied by HI-Systems since 1987.
|
|
| Locked | Locked | Locked |
Medical supplies and equipment are supplied to primary care professionals.
|
Detailed competitors of Ceban Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ceban Pharmaceuticals
Complete news archive for Ceban Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceban Pharmaceuticals
Ceban Pharmaceuticals was founded in 1980.
Ceban Pharmaceuticals is headquartered in Breda, Netherlands. It is registered at Breda, Noord-brabant, Netherlands.
Jeroen Van Der Hamsvoort is the current CEO of Ceban Pharmaceuticals.
Ceban Pharmaceuticals was established in 1980 and is headquartered in Breda, Netherlands. Operations are centered on the distribution of pharmaceutical products within the healthcare sector. Services encompass supply chain logistics and product delivery to various markets. The company is led by CEO Jeroen Van Der Hamsvoort, with activities focused on reliable pharmaceutical dissemination across Europe.
Ceban Pharmaceuticals's top competitors include AmerisourceBergen, Lagaay and Mach 2 Pharmafreight.
Ceban Pharmaceuticals offers Medsen Apotheken, Ceban Compounding, and Ceban HomeCare.
Ceban Pharmaceuticals has 1 investor. Key investors include Medios AG.